TonyM--Agree their current cash position is healthy so won't need cash infusion near term. I just don't see them paying off note from operating cash flow unless they can grow cord blood enrollments which have been in decline.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.